Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells
- PMID: 9018332
- DOI: 10.1002/(sici)1097-0045(19970101)30:1<26::aid-pros4>3.0.co;2-j
Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells
Abstract
The prostate gland of many animals accumulates extremely high levels of zinc and citrate. Evidence currently exists in support of a concept that zinc might be an important regulator of m-aconitase and citrate oxidation of prostate epithelial cells. No information concerning the mitochondrial levels of zinc has been available. The roles of testosterone and prolactin in the regulation of zinc have not been established. In this report, we determined the levels of tissue and mitochondrial zinc of rat lateral prostate (LP), ventral prostate (VP), dorsal prostate (DP), liver, and kidney. The results demonstrate that the mitochondrial zinc levels of the prostate cells were higher than levels of nonprostatic cells. The LP contained severalfold higher zinc levels than DP and VP. The effects of testosterone and prolactin in vivo and in vitro on the zinc levels were also determined. Both hormones significantly increased cellular and mitochondrial zinc levels of LP cells; decreased the zinc levels of VP cells; and had no effect on the zinc levels of DP, liver, or kidney cells. These effects are direct and physiological effects of the hormones on the targeted prostate epithelial cells. The hormonal effects on mitochondrial zinc of LP and VP epithelial cells correlate perfectly with their effects on citrate oxidation. The results support the concept that mitochondrial zinc is an inhibitor of m-aconitase and citrate oxidation; and that prolactin and testosterone regulation of mitochondrial zinc provides a mechanism for their regulation of citrate oxidation in citrate-producing prostate epithelial cells.
Similar articles
-
Prolactin specifically regulates citrate oxidation and m-aconitase of rat prostate epithelial cells.Metabolism. 1996 Apr;45(4):442-9. doi: 10.1016/s0026-0495(96)90217-6. Metabolism. 1996. PMID: 8609829 Free PMC article.
-
Mitochondrial aconitase gene expression is regulated by testosterone and prolactin in prostate epithelial cells.Prostate. 2000 Feb 15;42(3):196-202. doi: 10.1002/(sici)1097-0045(20000215)42:3<196::aid-pros5>3.0.co;2-8. Prostate. 2000. PMID: 10639190 Free PMC article.
-
Testosterone and prolactin stimulation of mitochondrial aconitase in pig prostate epithelial cells.Urology. 1996 Oct;48(4):654-9. doi: 10.1016/S0090-4295(96)00217-8. Urology. 1996. PMID: 8886079
-
Testosterone and prolactin regulation of metabolic genes and citrate metabolism of prostate epithelial cells.Horm Metab Res. 2002 Aug;34(8):417-24. doi: 10.1055/s-2002-33598. Horm Metab Res. 2002. PMID: 12198595 Free PMC article. Review.
-
Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer.Prostate. 1998 Jun 1;35(4):285-96. doi: 10.1002/(sici)1097-0045(19980601)35:4<285::aid-pros8>3.0.co;2-f. Prostate. 1998. PMID: 9609552 Review.
Cited by
-
Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers.Biomolecules. 2022 Dec 15;12(12):1880. doi: 10.3390/biom12121880. Biomolecules. 2022. PMID: 36551308 Free PMC article. Review.
-
A histidine-rich motif mediates mitochondrial localization of ZnT2 to modulate mitochondrial function.Am J Physiol Cell Physiol. 2011 Jun;300(6):C1479-89. doi: 10.1152/ajpcell.00420.2010. Epub 2011 Feb 2. Am J Physiol Cell Physiol. 2011. PMID: 21289295 Free PMC article.
-
A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.Arch Biochem Biophys. 2016 Dec 1;611:100-112. doi: 10.1016/j.abb.2016.04.014. Epub 2016 Apr 27. Arch Biochem Biophys. 2016. PMID: 27132038 Free PMC article. Review.
-
Terminal oxidation and the effects of zinc in prostate versus liver mitochondria.Mitochondrion. 2004 Aug;4(4):331-8. doi: 10.1016/j.mito.2004.07.031. Mitochondrion. 2004. PMID: 16120396 Free PMC article.
-
Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?Front Oncol. 2022 Jan 21;11:778761. doi: 10.3389/fonc.2021.778761. eCollection 2021. Front Oncol. 2022. PMID: 35127483 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources